ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
6 hedge funds and large institutions have $44.7K invested in ZyVersa Therapeutics in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
VF
1
Virtu Financial
New York
|
$0 |
| 2 |
2
Morgan Stanley
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
UBS Group
Zurich,
Switzerland
| $26.6K | 39,280 | +10,953 | +39% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $14.7K | 21,706 | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $3.06K | 4,525 | +2,370 | +110% |
|
4
Citigroup
New York
| $186 | 274 | +274 | New |
|
|
SS
5
SBI Securities
Tokyo,
Japan
| $102 | 151 | +101 | +202% |
|
6
Bank of America
Charlotte,
North Carolina
| $90 | 132 | +21 | +19% |
|
|
VF
7
Virtu Financial
New York
| – | – | -17,527 | Closed |
|
|
8
Morgan Stanley
New York
| – | – | -1 | Closed |
|